-transparent.png){kind=logo}
The efficacy and tolerability of the dihydropyridine derivative nisoldipine was assessed in 36 patients with primary Raynaud's phenomenon. Nisoldipine was given at doses of 5 mg and 10 mg daily for one month each in a placebo controlled double-blind cross-over trial. There was no subjective improvement in symptoms or changes in resting finger blood flow, platelet aggregability or red cell deformability after nisoldipine. The incidence of unwanted effects was similar to that previously described with nifedipine, suggesting that plasma concentrations of nisoldipine were sufficient to cause pharmacodynamic effects. Nisoldipine, in contrast to nifedipine is ineffective in the treatment of primary Raynaud's phenomen when given in a dose of up to 10 mg/day.
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
June 2003,
Clinical evidence,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
March 2011,
BMJ clinical evidence,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
June 2005,
Clinical evidence,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
October 2013,
BMJ clinical evidence,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
December 2004,
Clinical evidence,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
December 2008,
BMJ clinical evidence,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
January 1986,
European journal of clinical pharmacology,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
May 2008,
Zeitschrift fur Rheumatologie,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
May 2015,
The New Zealand medical journal,
V F Challenor, and
D G Waller, and
D A Francis, and
J L Francis, and
R Mani, and
S Roath
May 2021,
The Cochrane database of systematic reviews,
